NLRP12.com's blog with news, updates and comments on all things rare and autoinflammatory

  • Home
  • To NLRP12.com web site

Articles by John

Funding Restrictions

Humane Resources: Funding Restrictions in Rare Rheumatic Diseases

June 20, 2017 John 0

As any rheumatologist knows, most non-medical individuals don’t really know what ‘rheumatology’ is.  Not so much of a bad reputation, as no reputation.  Relatives and […]

Patient Engagement

Rare Disease Clinical Development: The Crucial Need for Patient and Parent Involvement

June 20, 2017 John 0

LuAnn Sabounjian, Head of Clinical Operations & Drug Safety, PROMETRIKA, LLC Rare Disease Clinical Trials February 28th, 2017 was the tenth observance of Rare Disease […]

NLRP12 FCAS2 RARE DISEASE

Living with a rare disease: a husband and father’s perspective

May 24, 2017 John 0

What does rare disease mean to you? To me, rare disease means a mutation called R1016X in a gene called NLRP12 on my son’s and […]

Global Genes Connect Collaborate Advance

Global Genes® to Convene RARE Partnering and Investor Forum to Accelerate Drug Development for Rare Diseases

May 23, 2017 John 0

[Aliso Viejo, CA] May 19, 2017 – Global Genes®, a leading rare disease patient advocacy organization, will host the inaugural RARE Partnering and Investor Forum, […]

Rare Voices Australia

Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays.

May 15, 2017 John 0

Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays. New paper from Orphanet J Rare Dis. 2017 Apr 11;12(1):68. doi: […]

Orphan Drugs

We must act as England falls behind on access to rare disease medicines

May 14, 2017 John 0

It is crucial that we develop a bespoke process to evaluate ‘orphan’ medicines if we are to eradicate inequality in the system, says Sebastian Stachowiak […]

app-based tool for clinicians

App-based tool for clinicians using facial recognition, AI and genetic big data to improve rare disease diagnosis and treatment

May 14, 2017 John 0

Boston startup FDNA, which makes a suite of apps called Face2Gene that use facial analysis, artificial intelligence and genomic insights in hopes of improving diagnoses […]

NHS Scotland

Three new medicines cleared for use by NHS Scotland

May 11, 2017 John 0

The Scottish Medicines Consortium has endorsed three medicines for routine use by NHS Scotland, offering new options to treat a rare eye disease, lupus and […]

NORD Launches Free CME Program to Educate Medical Professionals about Rare Diseases

May 10, 2017 John 0

he National Organization for Rare Disorders (NORD), the leading independent nonprofit organization representing the 30 million Americans with rare diseases, announces the launch of a […]

A Nuanced Message: Marketing to the Rare Diseases Community

May 10, 2017 John 0

Check traditional marketing strategies at the door, because when it comes to rare diseases they simply don’t apply. Experts say established methods of directing campaigns […]

Posts navigation

1 2 »

Navigation

  • Home
  • To NLRP12.com web site
  • FCAS2
  • NLRP12
  • Ultra Rare
  • Autoinflammatory
  • Drugs
    • Orphan Drugs
  • Pharma
  • Genetics
  • Autoimmune
  • Software
  • Rare Disease
  • Ultra Rare
  • UK
    • Scotland
      • NHS Scotland
    • Northern Ireland
    • Wales
    • England
  • USA
  • Campaigning
  • Uncategorized

What advice would you give to others?

  • Humane Resources: Funding Restrictions in Rare Rheumatic Diseases
  • Rare Disease Clinical Development: The Crucial Need for Patient and Parent Involvement
  • Living with a rare disease: a husband and father’s perspective
  • Global Genes® to Convene RARE Partnering and Investor Forum to Accelerate Drug Development for Rare Diseases
  • Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays.
  • We must act as England falls behind on access to rare disease medicines
  • App-based tool for clinicians using facial recognition, AI and genetic big data to improve rare disease diagnosis and treatment
  • Three new medicines cleared for use by NHS Scotland
  • NORD Launches Free CME Program to Educate Medical Professionals about Rare Diseases
  • A Nuanced Message: Marketing to the Rare Diseases Community
Advocacy Australian Autoimmune Autoinflammatory Campaigning Child Drug Costs England Genetics Hereditory Immune System India LHON Lifestyle Marketing NHS Scotland Pharma Rare Disease Rare Disease Marketing Rare Disease Registry SLE SMC UK ultra-rare USA
No comments found

Archives

| Privacy Policy | Terms & Conditions |
| Cookie Policy | Disclaimer |
Nothing on this blog is medical advice. This blog is for INFORMATION only.
If you need medical advice, please call a medical professional.

Copyright © 2023 | WordPress Theme by MH Themes